Delivery Order SPE2DB20D6037-SPE2DB24FTWV0

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,312.24 firm fixed-price delivery order is for the supply of 4564687136 units of 20 mg sumatriptan nasal sprays. This award is under a larger indefinite delivery contract (IDC) valued up to $499,999,999 held by DMS Pharmaceutical Group with the DLA. The...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,079.88 contract was issued by the Defense Logistics Agency (DLA) Medical Supply Chain division to provide Sumatriptan 20 mg nasal sprays. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue orders for a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order worth $2,984.80 for IMITREX 20 MG NASAL SPRAYS. The contract was awarded on February 15, 2022, with a completion date of February 16, 2022. The contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,567,692,724 units of Sumatriptan 20 mg nasal sprays. The $1,566.49 firm fixed-price contract was awarded on March 25, 2025 by the Defense Logistics Agency (DLA), with a period of performance ending on March 26, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,345.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SUMATRIPTAN 20 MG NASAL SPRAYS, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 4, 2025. This contract award is associated with a...
This is a $1,639.34 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for 4,565,766,308 units of Sumatriptan 20 mg nasal sprays, with an ultimate completion date of September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA Troop Support Medical to procure a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,565,827,998 units of Sumatriptan 20 mg nasal sprays. The firm-fixed-price delivery order contract has a ceiling value of $2,296.90 and an ultimate completion date of September 17, 2024. This award is not designated as a set-aside contract. Additionally, Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,582.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,201,682 units of SUMATRIPTAN 5 MG NASAL SPRAYS, with a completion date of February 7, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,804,778 units of Sumatriptan 20 mg nasal sprays. The firm-fixed-price contract has a ceiling value of $2,055.07 and is set to expire on September 16, 2024. The contract is not associated with a set-aside program. Amerisourcebergen holds several indefinite delivery contracts (IDCs) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,187.70, is for the delivery of sumatriptan succinate, a prescription migraine medication. The award is issued under the DLA's Medical Supply Chain division and is a delivery order under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB24FTWV0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,884.91, is for the delivery of 4,565,607,297 units of Sumatriptan 20 mg nasal sprays.

The award is part of a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This IDC complements DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain.

The contract does not have a set-aside designation and is expected to be completed by August 29, 2024.

Generated 11/27/24, 9:08 AM